SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-076571
Filing Date
2022-07-01
Accepted
2022-07-01 08:46:52
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2219098d1_s3.htm S-3 326111
2 EXHIBIT 4.5 tm2219098d1_ex4-5.htm EX-4.5 305010
3 EXHIBIT 4.6 tm2219098d1_ex4-6.htm EX-4.6 362991
4 EXHIBIT 5.1 tm2219098d1_ex5-1.htm EX-5.1 34829
5 EXHIBIT 23.1 tm2219098d1_ex23-1.htm EX-23.1 2634
6 EX-FILING FEES tm2219098d1_ex-filingfees.htm EX-FILING FEES 39247
7 GRAPHIC tm2219098d1_ex5-1img001.jpg GRAPHIC 4186
  Complete submission text file 0001104659-22-076571.txt   1077793
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265956 | Film No.: 221059750
SIC: 2834 Pharmaceutical Preparations